Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s diseaseRobert Gilmore, Jakob Begun, Yoon‐Kyo An et al.|Intestinal Research|2025Cited by 8
The Durability of Anti-TNF Therapy for Crohn’s Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug MonitoringRobert Gilmore, Emily K. Wright, Richard Fernandes et al.|Crohn s & Colitis 360|2025Cited by 1